IRCCS Istituti Fisioterapici Ospitalieri

Roma 144

0 studies enrolling now · 2 studies all time

What they study most

Cutaneous Melanoma, Metastatic Melanoma, Mucosal Melanoma, Unresectable Melanoma

Studies at this site

• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling
• Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 — Stopped early